Arterial embolization combined with local ablation for the treatment of recurrent and refractory chest wall tumors
10.3969/j.issn.1008-794X.2024.02.006
- VernacularTitle:动脉栓塞联合局部消融治疗复发性、难治性胸壁肿瘤
- Author:
Quanjun YAO
1
;
Hongtao HU
;
Hailiang LI
;
Chenyang GUO
;
Ke ZHAO
;
Yanan ZHAO
;
Weili XIA
;
Yanan LI
Author Information
1. 450008 河南郑州 河南省肿瘤医院(郑州大学附属肿瘤医院)微创介入科
- Keywords:
arterial embolization;
local ablation;
recurrent and refractory chest wall tumor
- From:Journal of Interventional Radiology
2024;33(2):135-139
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the safety and efficacy of arterial embolization combined with local ablation in the treatment of recurrent and refractory chest wall tumors.Methods The clinical data of 11 patients with chest wall tumor that recurred after surgery and progressed after treatment were retrospectively analyzed.On the basis of the original treatment regimen,DSA-guided arterial embolization and CT-guided local ablation were employed.VAS score of pain relief and postoperative complications were recorded,and the therapeutic efficacy was evaluated Results All the patients were follow up for a median time of 18.5 months.Successful DSA-guided arterial embolization was accomplished in all patients.Seven patients(9 lesions in total)initially received CT-guided radiofrequency ablation(RFA),and tumor reoccurred in 2 patients,who had to receive RFA once more.Four patients(5 lesions in total)initially received CT-guided microwave ablation(MWA),and tumor reoccurred in one patient,who had to receive MWA again.According to mRECIST criteria,the 6-month,12-month and 18-month objective response rates(ORR)were 72.7%(8/11),45.5%(5/11)and 18.2%(2/11)respectively,the 6-month,12-month and 18-month overall survival rates were 81.8%(9/11),63.6%(7/11)and 27.3%(3/11)respectively,with a median survival time of 13.2 months.The postoperative one-month and 3-month VAS scores were(2.42±1.25)points and(1.91±1.24)points respectively,which were strikingly lower than preoperative(6.78±1.13)points,the differences were statistically significant(P＜0.05).After surgery,3 patients developed pleural effusion,which disappeared after puncture and drainage treatment,and 2 patients developed fever,which was improved after symptomatic treatment.One patient died of respiratory failure six months after treatment.Conclusion Arterial embolization combined with local ablation can improve the symptoms of pain and prolong the survival time of patients with chest wall tumors.This combination therapy is less traumatic and clinically safe,and it can be used as an effective treatment for patients with recurrent and refractory chest wall tumors.
